Concepedia

Wangjia Cao

WC

4

Publications

165

Citations

4

H-Index

2020

Active since

Affiliations

China Pharmaceutical University(Current)

State Key Laboratory of Natural Medicine

Wangjia Cao is an author at China Pharmaceutical University specializing in medicine, tumor biology, and disease susceptibility.

Top concepts

MedicineAllergyOncologyPathologyImmunologyMicrobiomeCell BiologyInflammationMicrobiologyBreast Cancer

Publications per year

2020–2022

4

Publications

4

ALDOA maintains NLRP3 inflammasome activation by controlling AMPK activation

Dongsheng Bai, Jiaying Du, Xiumin Bu et al. · Autophagy · 2021 · 57 citations · Full text

Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis

Yue Cao, Wangjia Cao, Yangmin Qiu et al. · Pharmacological Research · 2020 · 54 citations

Breast Cancer Metastasis, Tumor Biology, Oroxylin A +10

Oroxylin A maintains the colonic mucus barrier to reduce disease susceptibility by reconstituting a dietary fiber-deprived gut microbiota

Dongsheng Bai, Tifan Sun, Jiawei Zhao et al. · Cancer Letters · 2021 · 38 citations

Inflammation, Chronic Inflammatory Diseases, Disease Susceptibility +14

The flavonoid GL‐V9 alleviates liver fibrosis by triggering senescence by regulating the transcription factor GATA4 in activated hepatic stellate cells

Jiawei Zhao, Dongsheng Bai, Lei Qi et al. · British Journal of Pharmacology · 2022 · 16 citations · Full text

Rows per page

1–4 of 4